Open AccessEffects of Long-Term Oral Dipyridamole Treatment on Coronary Microcirculatory Function in Patients With Chronic Stable Angina: A Substudy of the Persantine In Stable Angina (PISA) Study
Author(s) -
Rohan Jagathesan,
Stuart D. Rosen,
Rodney A. Foale,
Paolo G. Camici,
Eugenio Picaño
Publication year - 2006
Publication title -
journal of cardiovascular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/01.fjc.0000245404.20922.9f
Subject(s) - dipyridamole , medicine , coronary flow reserve , coronary artery disease , placebo , cardiology , angina , perfusion , coronary circulation , blood flow , dobutamine , hemodynamics , anesthesia , myocardial infarction , alternative medicine , pathology
A meta-analysis of 13 randomized placebo-controlled trials demonstrated a benefit for dipyridamole therapy, particularly with longer duration of treatment. Although the mechanism of this effect is not well understood, dipyridamole increases endogenous tissue adenosine, which may have a beneficial effect on myocardial perfusion. Therefore, we measured the effects of dipyridamole on myocardial blood flow (MBF) and coronary flow reserve (CFR) by using positron emission tomography and H2O in patients with coronary artery disease.